Skip to main content
Year archive

Heidelberg Pharma AG — 2023 filings

All 34 regulatory filings released by Heidelberg Pharma AG (HPHA) in 2023, sourced directly from the official regulator.

34 Filings
2023 Period
2023 filings (34)
Filing Released Lang
Heidelberg Pharma AG: Prof. Dr. Andreas Pahl, buy
Director's Dealing
2023-12-18 English
Heidelberg Pharma AG: Heidelberg Pharma Announces Changes to the Executive Management Board
Board/Management Information
2023-11-29 English
Heidelberg Pharma AG: Heidelberg Pharma Announces Changes to the Executive Management Board
Board/Management Information
2023-11-29 English
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.12.2022 bis zum 30.11.2023
Audit Report / Information FY 2023
2023-11-20 German
Heidelberg Pharma Secures Patent for the Use of its ADC Technology Platform
Regulatory Filings
2023-11-15 English
Heidelberg Pharma Presents New Clinical Data from its Lead Candidate HDP-101 at the ASH Annual Meeting 2023
Regulatory Filings
2023-11-02 English
Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2023
Earnings Release 9M 2023
2023-10-12 English
Quartalsfinanzbericht
Interim / Quarterly Report 9M 2023
2023-10-12 German
Q3 statement / Q3 financial report 2022/2023
Interim / Quarterly Report 9M 2023
2023-10-12 English
Heidelberg Pharma AG: Heidelberg Pharma Provides Update on Phase I/IIa Clinical Trial with Lead Candidate HDP-101
Earnings Release FY 2023
2023-09-19 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2023-08-31 English
Heidelberg Pharma AG: Heidelberg Pharmas Partner Takeda Reached Development Milestone
Regulatory Filings
2023-08-08 English
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.12.2021 bis zum 30.11.2022
Audit Report / Information FY 2022
2023-07-18 German
Heidelberg Pharma Reports on First Half-Year 2023 and the Course of Business
Earnings Release H1 2023
2023-07-13 English
Halbjahresfinanzbericht nach WpHG für den Zeitraum vom 01.12.2022 bis zum 31.05.2023
Interim / Quarterly Report H1 2023
2023-07-13 German
Half-yearly financial report 2022/2023
Interim / Quarterly Report H2 2023
2023-07-13 German
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2023-06-30 English
Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeutics
M&A Activity
2023-06-29 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2023-05-31 English
Heidelberg Pharma AG: Prof. Dr. Andreas Pahl, buy
Director's Dealing
2023-05-26 English
Heidelberg Pharma reports on the results of the Annual General Meeting 2023
AGM Information
2023-05-25 English
Heidelberg Pharma appoints Chief Financial Officer
Board/Management Information
2023-05-05 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2023-04-28 English
Q1 statement / Q1 financial report 2022/2023
Interim / Quarterly Report Q1 2023
2023-04-19 English
Heidelberg Pharma AG: Bekanntmachung der Einberufung zur Hauptversammlung am 25.05.2023 in Ladenburg mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2023-04-13 German
Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2023
Interim / Quarterly Report Q1 2023
2023-04-13 English
Heidelberg Pharma Presents New Preclinical Data from its Proprietary ATAC Technology Platform at AACR Annual Meeting 2023
Regulatory Filings
2023-04-04 English
Annual financial report 2021/2022
Annual Report FY 2022
2023-03-28 English
Heidelberg Pharma concludes very successful financial year 2022 and reports on course of business
Earnings Release FY 2022
2023-03-24 English
Report Publication Announcement 2023
Report Publication Announcement
2023-02-20 English
Hinweis auf Konzernabschluss vom 01.12.2021 bis zum 30.11.2022
Report Publication Announcement
2023-02-20 German
Hinweis auf Konzernabschluss vom 01.12.2021 bis zum 30.11.2022
Report Publication Announcement
2023-02-20 German
Hinweis auf Jahresfinanzbericht vom 01.12.2021 bis zum 30.11.2022
Report Publication Announcement
2023-02-20 German
Hinweis auf Halbjahresfinanzbericht vom 01.12.2022 bis zum 31.05.2023
Report Publication Announcement
2023-02-20 German